Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

McKesson Corp (NY:MCK)

942.31 +7.10 (+0.76%)
Streaming Delayed Price Updated: 2:47 PM EST, Feb 11, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about McKesson Corp

< Previous 1 2 3 4 5 6 7 8 9
...
20 21 Next >
News headline image
5 Insightful Analyst Questions From McKesson’s Q4 Earnings Call
McKesson’s fourth-quarter results met Wall Street’s revenue expectations and modestly exceeded consensus for non-GAAP earnings per share, with the market responding positively. Management attributed... 
Via StockStory
Topics Artificial Intelligence Earnings
News headline image
McKesson (MCK): A Structural Re-rating Driven by Oncology and GLP-1 Momentum
McKesson Corporation (NYSE: MCK) stands today as the undisputed titan of the U.S. pharmaceutical supply chain. While the company has long been a staple of the Fortune 500, its relevance has surged in... 
Via Finterra
Topics Artificial Intelligence Economy Fraud
Thursday's session: top gainers and losers in the S&P500 index ↗
Via Chartmill
McKesson Corp (NYSE:MCK) Reports Mixed Q3 2026 Results and Raises Full-Year Profit Outlook ↗
Via Chartmill
McKesson Corp (NYSE:MCK) Fits the 'Affordable Growth' Investment Profile ↗
Via Chartmill
McKesson Corp (NYSE:MCK) Demonstrates Strong Growth and Technical Breakout Potential ↗
Via Chartmill
News headline image
How the Largest IPO of 2025 Could Be Healthy for Your Portfolio ↗
Medline is an appealing investment candidate – it has solid growth, operates in a steady industry, and a storied history. 
Via The Motley Fool
Topics Economy Initial Public Offering
News headline image
MCK Q4 Deep Dive: Oncology, Tech Investments, and Portfolio Focus Drive Growth
Healthcare distributor and services company McKesson (NYSE:MCK) met Wall Street’s revenue expectations in Q4 CY2025, with sales up 11.4% year on year to $106.2 billion. Its non-GAAP profit of $9.34 per... 
Via StockStory
News headline image
McKesson (MCK) Q3 2026 Earnings Call Transcript ↗
McKesson (MCK) Q3 2026 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
News headline image
McKesson (NYSE:MCK) Reports Q4 CY2025 In Line With Expectations
Healthcare distributor and services company McKesson (NYSE:MCK) met Wall Street’s revenue expectations in Q4 CY2025, with sales up 11.4% year on year to $106.2 billion. Its non-GAAP profit of $9.34 per... 
Via StockStory
News headline image
Earnings To Watch: McKesson (MCK) Reports Q4 Results Tomorrow
Healthcare distributor and services company McKesson (NYSE:MCK) will be announcing earnings results this Wednesday after the bell. Here’s what to expect. 
Via StockStory
News headline image
One Fund Bought Up Henry Schein Stock Amid Record Quarterly Results and a New $200 Million Efficiency Plan ↗
An improving earnings profile, aggressive buybacks, and a renewed focus on margins might be changing how long-term investors think about this healthcare distributor. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
McKesson Corp (NYSE:MCK): A GARP Stock with Strong Growth at a Reasonable Price ↗
McKesson Corp exemplifies GARP investing, offering strong earnings growth at a reasonable valuation within the vital healthcare supply chain. 
Via Chartmill
News headline image
1 Large-Cap Stock with Impressive Fundamentals and 2 Facing Challenges
Large-cap stocks are known for their staying power and ability to weather market storms better than smaller competitors. However, their sheer size makes it more challenging to maintain high growth... 
Via StockStory
News headline image
3 Big Reasons to Love McKesson (MCK)
McKesson trades at $825.38 and has moved in lockstep with the market. Its shares have returned 14.5% over the last six months while the S&P 500 has gained 12.9%. 
Via StockStory
Topics Stocks Supply Chain
News headline image
Citius Oncology Transitions to Commercial Stage: Analyzing the 10-K Filing and the 2026 Outlook for LYMPHIR
CRANFORD, NJ — As the 2025 calendar year draws to a close, Citius Oncology, Inc. (Nasdaq: CTOR) has reached a pivotal juncture in its corporate evolution. Following the release of its SEC 10-K filing... 
Via MarketMinute
Topics Economy Regulatory Compliance
News headline image
Medline’s Blockbuster IPO Ignites Market Optimism: The Largest Debut Since 2021
In a stunning return to the public stage, Medline Industries (Nasdaq: MDLN) successfully executed the largest initial public offering (IPO) in the United States since 2021, pricing its shares at the... 
Via MarketMinute
Topics Economy Initial Public Offering World Trade
News headline image
Medline Industries (MDLN) Deep-Dive: The $54 Billion Return of a Healthcare Titan
The global healthcare landscape shifted decisively on December 16, 2025, with the public market return of Medline Industries (Nasdaq: MDLN). After four years under the stewardship of a private equity... 
Via PredictStreet
Topics Artificial Intelligence Earnings Economy
News headline image
McKesson Corp (NYSE:MCK) Presents a Compelling Growth and Technical Breakout Setup ↗
McKesson Corp combines strong earnings growth with a bullish technical setup, offering a potential entry point in the healthcare sector. 
Via Chartmill
News headline image
2 S&P 500 Stocks with Competitive Advantages and 1 We Question
The S&P 500 (^GSPC) is often seen as a benchmark for strong businesses, but that doesn’t mean every stock is worth owning. Some companies face significant challenges, whether it’s stagnating growth,... 
Via StockStory
Topics Stocks
News headline image
2 Growth Stocks to Add to Your Roster and 1 We Avoid
Growth is oxygen. But when it evaporates, the consequences can be severe - ask anyone who bought Cisco in the Dot-Com Bubble or newer investors who lived through the 2020 to 2022 COVID cycle. 
Via StockStory
Topics Economy
News headline image
1 Healthcare Stock with Impressive Fundamentals and 2 We Brush Off
Personal health and wellness is one of the many secular tailwinds for healthcare companies. Players catalyzing medical advancements have benefited from elevated demand, which has supported the... 
Via StockStory
Topics Stocks
News headline image
Which S&P500 stocks are moving on Wednesday? ↗
Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Wednesday. 
Via Chartmill
News headline image
Tuesday's session: top gainers and losers in the S&P500 index ↗
Let's have a look at the top S&P500 gainers and losers one hour before the close of the markets of today's session. 
Via Chartmill
News headline image
These S&P500 stocks are moving in today's session ↗
Stay informed about the performance of the S&P500 index in the middle of the day on Tuesday. Uncover the top gainers and losers in today's session for valuable insights. 
Via Chartmill
News headline image
McKesson Corp (NYSE:MCK) Presents a Classic 'Growth at a Reasonable Price' Opportunity ↗
McKesson Corp exemplifies GARP investing, offering strong earnings growth at a reasonable valuation, backed by solid profitability and financial strength. 
Via Chartmill
News headline image
3 Cash-Producing Stocks Worth Your Attention
Free cash flow is one of the most reliable indicators of financial durability. These businesses not only generate cash but reinvest intelligently to sustain momentum. 
Via StockStory
News headline image
Treasury Yields Surge Amid Global Shifts and Fiscal Concerns: A Deep Dive into Market Implications
New York, NY – December 1, 2025 – U.S. Treasury yields have experienced a significant climb today, marking a pivotal moment for financial markets. This ascent, driven by a complex interplay of global... 
Via MarketMinute
Topics Bonds Credit Cards Economy
News headline image
2 Mooning Stocks to Target This Week and 1 Facing Challenges
Each stock in this article is trading near its 52-week high. These elevated prices usually indicate some degree of investor confidence, business improvements, or favorable market conditions. 
Via StockStory
News headline image
Freeport-McMoRan, Cisco, Teradyne And A Health Care Stock: CNBC's 'Final Trades' ↗
Freeport-McMoRan, Cisco, Teradyne and McKesson each get a shoutout on the latest edition of CNBC's 'Final Trades.' 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
20 21 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.